Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the most frequent primary liver cancer and occurs mainly in patients with liver cirrhosis. The mammalian target of rapamycin (mTOR) signaling pathway is involved in many hallmarks of cancer including cell growth, metabolism re-programming, proliferation and inhibiti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrín, Gustavo, Guerrero, Marta, Amado, Víctor, Rodríguez-Perálvarez, Manuel, De la Mata, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072933/
https://www.ncbi.nlm.nih.gov/pubmed/32070029
http://dx.doi.org/10.3390/ijms21041266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072933/
https://www.ncbi.nlm.nih.gov/pubmed/32070029
http://dx.doi.org/10.3390/ijms21041266

Ejemplares similares